Neurologist, Department of Clinical Neurosciences, Geneva University Hospital
Starting Comprehensive Multiple Sclerosis Care at Initial Diagnosis: Mary R. Rensel, MD, FAAN, ABIHM
Examining Tominersen as a Potential Treatment for Huntington Disease: The GENERATION HD2 trial
Gene Therapy, ASOs, and Beyond: What’s Coming for Huntington’s Disease
ADDRESS-LC Study of Long COVID Initiated, Phase 4 Trial Testing IVIg Transition to Efgartigimod, Lack of Rebound Effect Seen in Ozanimod